- Home
- TCRT vs ITOC Comparison
TCRT vs ITOC Comparison
Compare TCRT & ITOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TCRT | ITOC |
|---|---|---|
| Founded | 1998 | 1998 |
| Country | United States | China |
| Employees | N/A | 7 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3M | 5.6M |
| IPO Year | 2025 | N/A |
Fundamental Metrics
Financial Performance| Metric | TCRT | ITOC |
|---|---|---|
| Price | $2.10 | $0.33 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 12.5K | ★ 146.7K |
| Earning Date | 05-14-2026 | 03-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 24.66 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $15,900,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.67 | $0.25 |
| 52 Week High | $4.57 | $1.15 |
Technical Indicators
Market Signals| Indicator | TCRT | ITOC |
|---|---|---|
| Relative Strength Index (RSI) | 44.02 | 50.54 |
| Support Level | $1.92 | $0.28 |
| Resistance Level | $2.43 | $0.34 |
| Average True Range (ATR) | 0.14 | 0.02 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 24.00 | 32.70 |
Price Performance
Historical ComparisonAbout TCRT Alaunos Therapeutics Inc.
Alaunos Therapeutics Inc is a preclinical-stage biopharmaceutical company focused on the development of novel, orally administered small-molecule therapeutics for obesity and related metabolic disorders, such as metabolic dysfunction-associated steatotic liver disease (MASLD, a type of fatty liver disease). The program aims to develop a differentiated, non-hormonal, non-incretin approach, unlike hormone-based treatments like GLP-1 drugs. It has a single reportable and operating segment related to biopharmaceutical research and development.
About ITOC iTonic Holdings Ltd Class A Ordinary Shares
iTonic Holdings Ltd through its subsidiary, focuses on healthcare solutions for brachytherapy, a targeted radiation therapy used in cancer treatment. Its product, Beijing Feitian's Treatment Planning System, helps ensure safe and effective brachytherapy using radioactive sources inside the patient to kill cancer cells and shrink tumors. Its product portfolio also includes Medical Auxiliary Supplies such as seed implant needles, computer workstations, patient positioning device, etc.